Abstract
We report two cases of muscle-invasive bladder cancer (MIBC) with increasing multiple osteoblastic bone lesions but shrinking other lesions in response to chemotherapy. Case 1 had MIBC and received radical cystectomy followed by adjuvant gemcitabine plus cisplatin chemotherapy (GC). Three years after, follow computed tomography (CT) showed development of multiple lymph node metastasis, and then we performed GC as a first-line systemic chemotherapy. After two cycles of GC, CT showed de novo multiple osteoblastic lesions although metastatic lymph nodes were shrunk. Biopsy of the sternum revealed metastatic urothelial carcinoma. Case 2 had MIBC with multiple osteoblastic lesions on CT and bone scintigraphy, which was initially diagnosed as cT3bN0M1. After one cycle of GC, the number of osteoblastic lesions obviously increased although bladder tumor was regressed. Since the clinical course was unusual, biopsy of the clavicle was done. The histological diagnosis was benign osteoblastic bone disease, then the clinical diagnosis was revised to non-metastatic MIBC, and radical cystectomy was performed. Ten months after surgery, the patients complained worsening backache and CT showed increase in number of osteoblastic lesions. Eventually, ilium biopsy revealed bone metastasis of urothelial carcinoma. In case of atypical finding and unusual clinical course, biopsy of suspected metastatic lesion may be informative although adequate sampling should be secured.
Similar content being viewed by others
References
Tsuda Y, Nakagawa T, Shinoda Y et al (2017) Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis. Int J Clin Oncol 22:548–553
George S, John S, Maja H (2018) Chemotherapy-induced metastasis: mechanisms and translational opportunities. Clin Exp Metastasis 35:269–284
Bambury RM, Bhatt AS, Riester M et al (2015) DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors. BMC Cancer 15:242
Ruhs SA, El-Khoury GY, Chrischilles EA (1996) A cost minimization approach to the diagnosis of skeletal neoplasms. Skelet Radiol 25:449–454
Wallace MT, Lin PP, Bird JE et al (2019) The accuracy and clinical utility of intraoperative frozen section analysis in open biopsy of bone. J Am Acad Orthop Surg 27(11):410–417
Tian R, Minggang Su, Tian Ye et al (2009) Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skelet Radiol 38:451–458
Iwamura H, Kaiho Y, Ito J et al (2018) Evaluation of tumor viability for primary and bone metastases in metastatic castration-resistant prostate cancer using whole-body magnetic resonance imaging. Case Rep Urol 2018:4074378
Winters BR, De Sarlar N, Arora S et al (2019) Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy. JCI Insight 5(13):e128728. https://doi.org/10.1172/jci.insight.128728
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ogasawara, T., Tanaka, T., Shindo, T. et al. Two cases of osteoblastic bone metastasis from muscle-invasive bladder cancer with discrepancy in response to chemotherapy: problems and limitations of bone biopsy. Int Canc Conf J 9, 235–239 (2020). https://doi.org/10.1007/s13691-020-00435-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-020-00435-1